☆ 4.7 Editorial Material

Editorial: treat-to-target in ulcerative colitis clinical management-a small price to pay?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild-moderate ulcerative colitis

Paolo Angelo Cortesi et al.

Summary: This study assessed the cost-effectiveness of a treat-to-target strategy based on clinical signs and faecal calprotectin levels in patients with mild-moderate ulcerative colitis. The results showed that this approach increased the time spent in clinical remission and reduced the number of relapses compared to a strategy based solely on symptoms. However, it was also associated with higher costs.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Article Gastroenterology & Hepatology

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

Tim Raine et al.

JOURNAL OF CROHNS & COLITIS (2022)

Add to Collection

Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation

K. T. Park et al.

INFLAMMATORY BOWEL DISEASES (2020)

Add to Collection

Review Gastroenterology & Hepatology

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Jean-Frederic Colombel et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection

Editorial: treat-to-target in ulcerative colitis clinical management-a small price to pay?

Related references

Non-invasive monitoring and treat-to-target approach are cost-effective in patients with mild-moderate ulcerative colitis

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Export Citation

Share Paper